{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:07:33Z","timestamp":1759410453704},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":593,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jval.2011.05.045","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T23:35:36Z","timestamp":1312673736000},"page":"1019-1027","source":"Crossref","is-referenced-by-count":16,"title":["Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil"],"prefix":"10.1016","volume":"14","author":[{"given":"Patricia Coelho","family":"de Soarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Marli C.","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"de Andrade Lagoa N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Itria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillegonda Maria Dutilh","family":"Novaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2011.05.045_bib1","first-page":"1458","article-title":"[Meningococcal disease in Sao Paulo, Brazil, in the 20th century: epidemiological characteristics]","volume":"21","author":"de Moraes","year":"2005","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.jval.2011.05.045_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/S1413-86702004000300008","article-title":"Three decades of meningococcal disease in the state of Santa Catarina, Brazil","volume":"8","author":"Puricelli","year":"2004","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jval.2011.05.045_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/016164110X12644252260754","article-title":"Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention","volume":"32","author":"Safadi","year":"2010","journal-title":"Neurol Res"},{"key":"10.1016\/j.jval.2011.05.045_bib5","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Informe Regional de SIREVA II, 2007. Datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos envasores. Documentos T\u00e9cnicos. Tecnologia Esenciales de Salud. THR\/HT - 2008\/003."},{"key":"10.1016\/j.jval.2011.05.045_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jval.2011.05.045_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erv.10.3","article-title":"The epidemiology of meningococcal disease and the impact of vaccines","volume":"9","author":"Khatami","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jval.2011.05.045_bib9","series-title":"Departamento de Ci\u00eancia e Tecnologia","year":"2009"},{"key":"10.1016\/j.jval.2011.05.045_bib10","series-title":"Applied methods of cost-effectiveness analysis in health care","author":"Gray AM","year":"2011"},{"key":"10.1016\/j.jval.2011.05.045_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1017\/S0266462399153108","article-title":"Probabilistic sensitivity analysis in cost-effectiveness","volume":"15","author":"Whang","year":"1999","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jval.2011.05.045_bib12","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1016\/j.vaccine.2009.06.096","article-title":"Household survey of hepatitis B vaccine coverage among Brazilian children","volume":"27","author":"Luna","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2011.05.045_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2011.05.045_bib14","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2011.05.045_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/INF.0b013e31819040e7","article-title":"The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada","volume":"28","author":"Bettinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"10.1016\/j.jval.2011.05.045_bib16","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2011.05.045_bib17","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1016\/j.vaccine.2009.01.045","article-title":"Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain)","volume":"27","author":"Martinez","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.jval.2011.05.045_bib18","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1086\/431513","article-title":"Projected cost-effectiveness of rotavirus vaccination for children in Asia","volume":"192","author":"Podewils","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jval.2011.05.045_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/S0037-86822007000300011","article-title":"[Meningococcal disease: comparison between clinical forms]","volume":"40","author":"Stella-Silva","year":"2007","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.jval.2011.05.045_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1590\/S0004-282X2004000400013","article-title":"[Audiologic late prognosis due to meningitis in children]","volume":"62","author":"Anjos","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jval.2011.05.045_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0004-282X2004000300009","article-title":"Sequelae from meningococcal meningitis in children: a critical analysis of dexamethasone therapy","volume":"62","author":"Casella","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jval.2011.05.045_bib26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1590\/S0004-282X1999000500012","article-title":"[Audiological assessment and follow-up after bacterial meningitis]","volume":"57","author":"Couto","year":"1999","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jval.2011.05.045_bib28","unstructured":"Minist\u00e9rio da Sa\u00fade. DATASUS. Sistema de Informa\u00e7\u00e3o Hospitalar (SIH\/DATASUS). Cd-rom, 2006."},{"key":"10.1016\/j.jval.2011.05.045_bib31","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/S0264-410X(02)00161-5","article-title":"Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec","volume":"20","author":"De Wals","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2011.05.045_bib32","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.vaccine.2003.09.022","article-title":"Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease","volume":"22","author":"De Wals","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2011.05.045_bib33","series-title":"The world report 2002 - reducing risks, promoting healthy life","year":"2002"},{"key":"10.1016\/j.jval.2011.05.045_bib34","article-title":"Threshold values for cost-effectiveness in health care","author":"Cleemput","year":"2008"},{"key":"10.1016\/j.jval.2011.05.045_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/11535280-000000000-00000","article-title":"Methodological concerns with economic evaluations of meningococcal vaccines","volume":"28","author":"Kauf","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2011.05.045_bib36","first-page":"227","article-title":"Reduction in invasive meningococcal disease in Queensland: a success for immunisation","volume":"31","author":"Slinko","year":"2007","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.jval.2011.05.045_bib37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0277-9536(98)00419-5","article-title":"A cost-effectiveness analysis of vaccination strategies against N meningitidis meningitis in sub-Saharan African countries","volume":"48","author":"Bovier","year":"1999","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jval.2011.05.045_bib39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1590\/S1413-86702007000600014","article-title":"Neisseria meningitidis: a neglected cause of infectious haemorrhagic fever in the amazon rainforest","volume":"11","author":"Barroso","year":"2007","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jval.2011.05.045_bib40","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1524-4733.2010.00771.x","article-title":"What do international pharmacoeconomic guidelines say about economic data transferability?","volume":"13","author":"Barbieri","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2011.05.045_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/eurpub\/10.1.24","article-title":"Methodology: disability weights for diseases","volume":"10","author":"Stouthard","year":"2000","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.jval.2011.05.045_bib42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00019053-200523090-00001","article-title":"The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine","volume":"23","author":"Welte","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2011.05.045_bib43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1367\/A03-178R.1","article-title":"Evidence that school-age children can self-report on their health","volume":"4","author":"Riley","year":"2004","journal-title":"Ambul Pediatr"},{"key":"10.1016\/j.jval.2011.05.045_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/hv.2.2.2611","article-title":"Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales","volume":"2","author":"Trotter","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jval.2011.05.045_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S1020-49892008000400001","article-title":"Cost-effectiveness analysis of routine rotavirus vaccination in Brazil","volume":"23","author":"de Soarez","year":"2008","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.jval.2011.05.045_bib46","article-title":"Cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the universal immunisation of infants in Brazil","author":"Sartori","year":"2010","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jval.2011.05.045_bib47","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/j.vaccine.2008.07.021","article-title":"Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil","volume":"26","author":"Valentim","year":"2008","journal-title":"Vaccine"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301511014963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301511014963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T03:00:28Z","timestamp":1592794828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301511014963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1098301511014963"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2011.05.045","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}